Skip to search formSkip to main contentSkip to account menu

pirozadil

Known as: 2,6-pyridinediyldimethylene bis(3,4,5-trimethoxybenzoate) 
A nicotinic acid derivative with antilipidemic activity.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
Six patients (four women and two men) with mild to moderate hypercholesterolemia, but with no clinical evidence of the disease… 
1989
1989
With the goal to evaluate the long term efficacy and tolerance of pirozadil, 20 patients with hypercholesterolemia (type II a… 
1989
1989
Abstract With the goal to evaluate the long term efficacy and tolerance of pirozadil, 20 patients with hypercholesterolemia (type… 
1987
1987
The lipid-lowering agent pirozadil was tested in 1185 hyperlipidaemic subjects during a 2-4 months' intake. Plasma triglycerides… 
1987
1987
Pirozadil (pyridine 2,6-dimethanol-bis(3,4,5-trimethoxybenzoate), Pemix) was administered for 16 weeks at a dose of 1.5 or 2.0 g… 
1986
1986
Experimental hyperlipidemia was induced in ddY, C57BL, BALB and ICR strain mice and in Wistar rats. By feeding the animals a high… 
1982
1982
Pirozadil and alufibrate are compared by a single-blind study over two groups 20 patients with primary hyperlipoproteinemia… 
1981
1981
The effect of pirozadil, a new hypolipidemic agent, on cerebral blood flow was tested in anesthetized dogs and compared to that…